2331:TSEALSOK CO., LTD. Analysis
Data as of 2026-05-18 - not real-time
HK$18.49
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Li Ning (2331.HK) is trading at HK$18.49, well below its 20‑day (≈19.88) and 200‑day (≈19.04) simple moving averages, indicating a price lag despite a relatively low 31.9 RSI that suggests the stock is oversold. Technical momentum remains bearish as the MACD line sits beneath its signal (‑0.57 vs ‑0.45) and volume is trending downward, yet the proximity to the identified support level of HK$18.05 offers a potential floor. Valuation metrics reinforce the upside case: the DCF‑derived fair value of roughly HK$22.0 and analyst consensus targets around HK$25.5 imply a 40%‑plus upside, while the current PE of 14.1 and forward PE of 11.9 are modest for a consumer‑cyclical brand.
Fundamentally, Li Ning boasts a strong balance sheet with HK$17.8 bn cash versus HK$2.1 bn debt (debt‑to‑equity ~7%), healthy gross margins near 49% and a ROE of 11%, supporting its ability to sustain a generous 3.4% dividend yield. The payout ratio of 77% is high but backed by solid free cash flow (≈HK$2.7 bn) and a low beta of 0.35, indicating limited market‑wide volatility despite a 30‑day price volatility of over 30%. Analyst sentiment is bullish (median recommendation “Buy”), and the Fear & Greed index at 89.6 reflects extreme market optimism, further underscoring the potential for price recovery.
Fundamentally, Li Ning boasts a strong balance sheet with HK$17.8 bn cash versus HK$2.1 bn debt (debt‑to‑equity ~7%), healthy gross margins near 49% and a ROE of 11%, supporting its ability to sustain a generous 3.4% dividend yield. The payout ratio of 77% is high but backed by solid free cash flow (≈HK$2.7 bn) and a low beta of 0.35, indicating limited market‑wide volatility despite a 30‑day price volatility of over 30%. Analyst sentiment is bullish (median recommendation “Buy”), and the Fear & Greed index at 89.6 reflects extreme market optimism, further underscoring the potential for price recovery.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Oversold RSI and price near support
- High dividend yield providing immediate income
- Potential bounce supported by low beta
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation upside to DCF fair value
- Strong cash position and low leverage
- Analyst consensus of Buy with favorable earnings outlook
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Brand positioning in China’s growing sports market
- Sustainable dividend policy backed by cash flow
- Undervalued relative to peers with modest earnings growth
Key Metrics & Analysis
Financial Health
Revenue Growth3.10%
Profit Margin9.92%
P/E Ratio14.1
ROE10.93%
ROA7.01%
Debt/Equity7.44
P/B Ratio1.5
Op. Cash FlowHK$4.9B
Free Cash FlowHK$2.7B
Technical Analysis
TrendNeutral
RSI31.9
SupportHK$18.05
ResistanceHK$21.80
MA 20HK$19.88
MA 50HK$20.56
MA 200HK$19.04
MACDBearish
VolumeDecreasing
Fear & Greed Index89.61
Valuation
Fair ValueHK$21.98
Target PriceHK$25.89
Upside/Downside40.03%
GradeUndervalued
TypeBlend
Dividend Yield3.39%
Risk Assessment
Beta0.35
Volatility32.86%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.